HopeStage
Back to all studies
Not Yet RecruitingNCT06518941

Donepezil and habit-related symptoms in anorexia nervosa

About this titleRead the official source — NCT06518941
Medication studyAges 18–60United StatesEating disorders
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: January 2027
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
10
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT06518941
Official title
Show the full official title

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

Recruitment & locations

Not yet recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Donepezil.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies